A citation-based method for searching scientific literature

Thomas Müller, Bernhard Klaus Mueller, Peter Riederer. Cells 2021
Times Cited: 5







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnostic staging of Parkinson's disease: conceptual aspects.
H Przuntek, Th Müller, P Riederer. J Neural Transm (Vienna) 2004
106
60

Amyloid beta: structure, biology and structure-based therapeutic development.
Guo-Fang Chen, Ting-Hai Xu, Yan Yan, Yu-Ren Zhou, Yi Jiang, Karsten Melcher, H Eric Xu. Acta Pharmacol Sin 2017
545
40


There is no Parkinson disease.
William J Weiner. Arch Neurol 2008
47
40

The "long and winding road" of the disease-modifying effects of levodopa has not ended yet.
Miguel Leal Rato, Olivier Rascol, Joaquim J Ferreira. Mov Disord 2020
5
40

Nonmotor fluctuations in Parkinson's disease: frequent and disabling.
Tatiana Witjas, E Kaphan, J P Azulay, O Blin, M Ceccaldi, J Pouget, M Poncet, A Ali Chérif. Neurology 2002
418
40

Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
Roberto Cilia, Emanuele Cereda, Albert Akpalu, Fred Stephen Sarfo, Momodou Cham, Ruth Laryea, Vida Obese, Kenneth Oppon, Francesca Del Sorbo, Salvatore Bonvegna,[...]. Brain 2020
35
40

Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
Thomas Müller, Isabel Trommer, Siegfried Muhlack, Bernhard K Mueller. J Neural Transm (Vienna) 2016
25
40

Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Stephen Mullin, Morten Gersel Stokholm, Derralyn Hughes, Atul Mehta, Peter Parbo, Rainer Hinz, Nicola Pavese, David J Brooks, Anthony H V Schapira. Mov Disord 2021
28
40

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
573
40

Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
Fatemeh N Emamzadeh, Andrei Surguchov. Front Neurosci 2018
175
40

Investigational agents for the management of Huntington's disease.
Thomas Müller. Expert Opin Investig Drugs 2017
7
40

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
Ann E Kingsbury, Rina Bandopadhyay, Laura Silveira-Moriyama, Hilary Ayling, Constantinos Kallis, William Sterlacci, Hans Maeir, Werner Poewe, Andrew J Lees. Mov Disord 2010
96
40

Prodromal Parkinson disease subtypes - key to understanding heterogeneity.
Daniela Berg, Per Borghammer, Seyed-Mohammad Fereshtehnejad, Sebastian Heinzel, Jacob Horsager, Eva Schaeffer, Ronald B Postuma. Nat Rev Neurol 2021
52
40

GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes.
Andrea Greuel, Jean-Pierre Trezzi, Enrico Glaab, Marina C Ruppert, Franziska Maier, Christian Jäger, Zdenka Hodak, Katja Lohmann, Yilong Ma, David Eidelberg,[...]. Mov Disord 2020
29
40


Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.
Avner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, Tanya Gurevich, Nurit Omer, Anat Bar-Shira, Mali Gana-Weisz, Orly Goldstein, Meir Kestenbaum, Jesse M Cedarbaum,[...]. Sci Rep 2020
15
40

The PRIPS study: screening battery for subjects at risk for Parkinson's disease.
D Berg, J Godau, K Seppi, S Behnke, I Liepelt-Scarfone, S Lerche, H Stockner, A Gaenslen, P Mahlknecht, H Huber,[...]. Eur J Neurol 2013
88
40

Metformin and reduced risk of cancer in diabetic patients.
Josie M M Evans, Louise A Donnelly, Alistair M Emslie-Smith, Dario R Alessi, Andrew D Morris. BMJ 2005
20

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.
Jolien de Jager, Adriaan Kooy, Philippe Lehert, Michiel G Wulffelé, Jan van der Kolk, Daniël Bets, Joop Verburg, Ab J M Donker, Coen D A Stehouwer. BMJ 2010
273
20

Glucose regulates amyloid β production via AMPK.
Ting-Ting Yang, Yao-Shan Shih, Yun-Wen Chen, Yu-Min Kuo, Chu-Wan Lee. J Neural Transm (Vienna) 2015
10
20

Traditional plant medicines as treatments for diabetes.
C J Bailey, C Day. Diabetes Care 1989
374
20

The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence.
Brhane Teklebrhan Assefa, Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Meles Tekie Gidey. Biomed Res Int 2020
19
20

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.
M Y El-Mir, V Nogueira, E Fontaine, N Avéret, M Rigoulet, X Leverve. J Biol Chem 2000
990
20


Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.
Suet Ching Chen, Rebecca Brooks, Jessica Houskeeper, Shaun K Bremner, Julia Dunlop, Benoit Viollet, Pamela J Logan, Ian P Salt, S Faisal Ahmed, Stephen J Yarwood. Mol Cell Endocrinol 2017
80
20

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus.
Maryam Paseban, Reza Mohebbati, Saeed Niazmand, Thozhukat Sathyapalan, Amirhossein Sahebkar. Biomolecules 2019
11
20

Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Carmen Infante-Garcia, Juan Jose Ramos-Rodriguez, Carmen Hierro-Bujalance, Esperanza Ortegon, Eleanor Pickett, Rosemary Jackson, Fernando Hernandez-Pacho, Tara Spires-Jones, Monica Garcia-Alloza. Mol Neurobiol 2018
24
20

Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia.
David S Knopman, Bradley F Boeve, Ronald C Petersen. Mayo Clin Proc 2003
131
20

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Angela L Guillozet, Sandra Weintraub, Deborah C Mash, M Marsel Mesulam. Arch Neurol 2003
391
20


Hypoglycaemic effect of Momordica charantia extracts.
C Day, T Cartwright, J Provost, C J Bailey. Planta Med 1990
67
20

Review of Biguanide (Metformin) Toxicity.
George Sam Wang, Christopher Hoyte. J Intensive Care Med 2019
39
20

Antioxidative properties of aspirin: dose dependence and clinical implications.
W Kuhn, T Müller, T Büttner, M Gerlach. Eur J Neurol 1996
6
20

Increased risk of cognitive impairment in patients with diabetes is associated with metformin.
Eileen M Moore, Alastair G Mander, David Ames, Mark A Kotowicz, Ross P Carne, Henry Brodaty, Michael Woodward, Karyn Boundy, Kathryn A Ellis, Ashley I Bush,[...]. Diabetes Care 2013
225
20


Systemic infections and inflammation affect chronic neurodegeneration.
V Hugh Perry, Colm Cunningham, Clive Holmes. Nat Rev Immunol 2007
707
20

AMPK: mediating the metabolic effects of salicylate-based drugs?
Gregory R Steinberg, Madhumita Dandapani, D Grahame Hardie. Trends Endocrinol Metab 2013
56
20

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Magdalena Markowicz-Piasecka, Joanna Sikora, Aleksandra Szydłowska, Agata Skupień, Elżbieta Mikiciuk-Olasik, Kristiina M Huttunen. Pharm Res 2017
139
20

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.
Qian Shi, Shuqian Liu, Vivian A Fonseca, Tina K Thethi, Lizheng Shi. BMJ Open 2019
50
20



Bitter melon: a panacea for inflammation and cancer.
Prasad R Dandawate, Dharmalingam Subramaniam, Subhash B Padhye, Shrikant Anant. Chin J Nat Med 2016
50
20

Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway.
Min-Jia Tan, Ji-Ming Ye, Nigel Turner, Cordula Hohnen-Behrens, Chang-Qiang Ke, Chun-Ping Tang, Tong Chen, Hans-Christoph Weiss, Ernst-Rudolf Gesing, Alex Rowland,[...]. Chem Biol 2008
216
20

Obesity and cognitive decline: role of inflammation and vascular changes.
Jason C D Nguyen, A Simon Killcross, Trisha A Jenkins. Front Neurosci 2014
212
20

Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice.
Joanne S Allard, Evelyn J Perez, Koji Fukui, Priscilla Carpenter, Donald K Ingram, Rafael de Cabo. Behav Brain Res 2016
54
20


The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Reuben J Shaw, Katja A Lamia, Debbie Vasquez, Seung-Hoi Koo, Nabeel Bardeesy, Ronald A Depinho, Marc Montminy, Lewis C Cantley. Science 2005
20

The Therapeutic Potential of Metformin in Neurodegenerative Diseases.
Carola Rotermund, Gerrit Machetanz, Julia C Fitzgerald. Front Endocrinol (Lausanne) 2018
144
20

Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.
José A Luchsinger, Thania Perez, Helena Chang, Pankaj Mehta, Jason Steffener, Gnanavalli Pradabhan, Masanori Ichise, Jennifer Manly, Davangere P Devanand, Emilia Bagiella. J Alzheimers Dis 2016
131
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.